CDSCO Shifts WHO-GMP and COPP Applications to ONDLS Portal

As part of a major step to digitisation of India’s pharmaceutical regulatory processes, the Central Drugs Standard Control Organisation (CDSCO) announced that effective 15 July 2025, all applications for World Health Organisation Good Manufacturin...

Study Flags Quality Failures in Indian-Made Chemotherapy Drugs

A new study has shown that many widely used generic chemotherapy medicines around the world have failed quality testing. This raises serious doubts about the safety and efficacy of cancer therapy in more than 100 countries. The affected drugs...

Govt Proposes Licence Suspension for Drugs Failing Quality Tests

The Union Health Ministry is looking to tighten drug quality regulations by proposing to immediately suspend manufacturing licenses of pharmaceutical companies for drugs that fail government lab testing. The change follows a recommendation from...

Natco Pharma's Hyderabad unit gets 7 USFDA Form 483 observations

Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...

Role of Optical Imaging in Early Cancer Detection and Treatment

In an interaction with India Pharma Outlook, Dr. Ganesh Babu, Head of Clinical and Regulatory Affairs at Carl Zeiss India, discusses how optical imaging technologies like fluorescence imaging and OCT are revolutionizing cancer detection. He highlight

India's Pharma Sector Faces Heightened FDA Scrutiny on Quality

India's domestic pharmaceutical industry will be subject to heightened scrutiny in light of ongoing quality control issues among domestic manufacturers, a reported by BMI stated...

Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks

Eli Lilly's experimental obesity drug, eloralintide, has shown promising early-stage data supporting weight loss of an average of 11.5 percent after only 12 weeks, said an investor note from Cantor Fitzgerald...

India's Diagnostic Labs Gear Up Amid Fresh Wave of Covid Infections

Leading diagnostic chains in India are scaling up operations amid a sharp rise in Covid-19 cases, driven by new variants such as JN.1, NB.1.8.1, and LF.7. According to diagnostic labs, RT-PCR tests have risen by 70 percent as people become more aware

Health Ministry Proposes Ban on 34 Antimicrobials in Animal Use

The Union Health Ministry has issued a draft notification proposing a ban on the manufacture, import, sale, and distribution of 34 antimicrobials

NABL Pushes Accredited Labs to Use Combined ILAC MRA Mark for Global Trust

The National Accreditation Board for Testing and Calibration Laboratories (NABL) is encouraging its accredited Conformity Assessment Bodies

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring